» Articles » PMID: 34326286

Regression of Hepatic Fibrosis and Evolution of Cirrhosis: A Concise Review

Overview
Journal Adv Anat Pathol
Date 2021 Jul 30
PMID 34326286
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Fibrosis is not a unidirectional, linear process, but a dynamic one resulting from an interplay of fibrogenesis and fibrolysis depending on the extent and severity of a biologic insult, or lack thereof. Regression of fibrosis has been documented best in patients treated with phlebotomies for hemochromatosis, and after successful suppression and eradication of chronic hepatitis B and C infections. This evidence mandates a reconsideration of the term "cirrhosis," which implies an inevitable progression towards liver failure. Furthermore, it also necessitates a staging system that acknowledges the bidirectional nature of evolution of fibrosis, and has the ability to predict if the disease process is progressing or regressing. The Beijing classification attempts to fill this gap in contemporary practice. It is based on microscopic features termed "the hepatic repair complex," defined originally by Wanless and colleagues. The elements of the hepatic repair complex represent the 3 processes of fragmentation and regression of scar, vascular remodeling (resolution), and parenchymal regeneration. However, regression of fibrosis does not imply resolution of cirrhosis, which is more than just a stage of fibrosis. So far, there is little to no evidence to suggest that large regions of parenchymal extinction can be repopulated by regenerating hepatocytes. Similarly, the vascular lesions of cirrhosis persist, and there is no evidence of complete return to normal microcirculation in cirrhotic livers. In addition, the risk of hepatocellular carcinoma is higher compared with the general population and these patients need continued screening and surveillance.

Citing Articles

Role of triggering receptor expressed on myeloid cells 2 in the pathogenesis of non-alcoholic fatty liver disease.

Zhang L, Liu S, Zhao Q, Liu X, Liu T, Zhang Q World J Hepatol. 2025; 17(2):102328.

PMID: 40027566 PMC: 11866134. DOI: 10.4254/wjh.v17.i2.102328.


Hepatitis C Virus-Core Antigen: Implications in Diagnostic, Treatment Monitoring and Clinical Outcomes.

Le D, Kanokudom S, Nguyen H, Yorsaeng R, Honsawek S, Vongpunsawad S Viruses. 2025; 16(12.

PMID: 39772172 PMC: 11680303. DOI: 10.3390/v16121863.


Metabolic dysfunction-associated steatotic liver disease: The question of long-term high-normal alanine aminotransferase as a screening test.

Moyana T World J Gastroenterol. 2024; 30(42):4576-4582.

PMID: 39563746 PMC: 11572615. DOI: 10.3748/wjg.v30.i42.4576.


Review of the Effects of Antiviral Therapy on Hepatitis B/C-Related Mortality and the Regression of Fibrosis.

Sinclair 3rd S, Shearen S, Ghobrial Y, Trad G, Abdul Basit S, Shih D Viruses. 2024; 16(10).

PMID: 39459866 PMC: 11512229. DOI: 10.3390/v16101531.


Contemporary Insights into Hepatitis C Virus: A Comprehensive Review.

Sallam M, Khalil R Microorganisms. 2024; 12(6).

PMID: 38930417 PMC: 11205832. DOI: 10.3390/microorganisms12061035.


References
1.
Wanless I, Nakashima E, Sherman M . Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med. 2000; 124(11):1599-607. DOI: 10.5858/2000-124-1599-ROHC. View

2.
Sakata K, Hara M, Terada T, Watanabe N, Takaya D, Yaguchi S . HCV NS3 protease enhances liver fibrosis via binding to and activating TGF-β type I receptor. Sci Rep. 2013; 3:3243. PMC: 3837337. DOI: 10.1038/srep03243. View

3.
Yang L, Inokuchi S, Roh Y, Song J, Loomba R, Park E . Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1. Gastroenterology. 2013; 144(5):1042-1054.e4. PMC: 3752402. DOI: 10.1053/j.gastro.2013.01.056. View

4.
Knauer C, Gamble C, MONROE L . The reversal of hemochromatotic cirrhosis by multiple phlebotomies. Report of a case. Gastroenterology. 1965; 49(6):667-71. View

5.
Kisseleva T, Brenner D . Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2020; 18(3):151-166. DOI: 10.1038/s41575-020-00372-7. View